Meanwhile, SMAD4, which is a central mediator of TGF-β signaling, remains functionally undruggable, as its tumor suppressor function is typically lost through biallelic inactivation rather than amenable to pharmacologic inhibition. The gene discussed is SMAD4; the disease is neoplasm.